Head-to-head comparisons of medication uses, side effects, warnings, and more.
Evenity (romosozumab)
Forteo (teriparatide)
Evenity (romosozumab)
Forteo (teriparatide)
Summary of Evenity vs. Forteo
Summary for Sclerostin inhibitor
Prescription only
Evenity (romosozumab or romosozumab-aqqg) is an injection used to treat osteoporosis (bone loss) in certain women after menopause. These women either have a high risk of fracture or can’t take other medications for bone loss. It's also used when these other medications haven’t worked well enough. Evenity (romosozumab) belongs to the drug class called sclerostin inhibitors. It works to help your bones grow and prevent bone breakdown at the same time. The injection is given once a month by a healthcare professional. Common side effects are joint pain and headache. There's also serious risks of heart attack and stroke. This medication is brand name only; there's no generic available yet.
Summary for Parathyroid hormone analog
Prescription only
Forteo (teriparatide) is used to treat osteoporosis (bone loss or weakening). It's for people who are at very high fracture risk or people who've already tried other osteoporosis medications. Forteo (teriparatide) is an injection that you give to yourself once a day. Some common side effects include general body pain and joint pain. This medication comes as a prefilled pen, but it doesn't come with pen needles. Forteo (teriparatide) is only available as a brand medication; there's no generic version yet.
•Helps with bone growth and prevents bone loss at the same time
•Given just once a month
•Only need 1 year of treatment
Cons
•Needs to be injected
•Must go to the medical office for each injection
•Bone mineral density eventually goes back to where it was before after stopping the medication
Pros and Const for Parathyroid hormone analog
Pros
•Can use if you're unable to take or still getting fractures with other osteoporosis medications
•A first-choice option for people at very high fracture risk (have had a fracture caused by osteoporosis before or have many risk factors for fracture)
•Lowers the risk for back fractures and fractures in other parts of the body (not including the hip) in postmenopausal women with osteoporosis